Parya Saberi
Overview
Explore the profile of Parya Saberi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
101
Citations
1154
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moameri H, Goudarzi R, Haghdoost A, Gouya M, Saberi P, Mirzazadeh A, et al.
Sci Rep
. 2025 Mar;
15(1):7747.
PMID: 40044976
The Iranian government does not fund pre-exposure prophylaxis (PrEP), and it is not used in Iran due to uncertainties in its cost-effectiveness. In this study, we examined the cost-effectiveness of...
2.
Moran L, Bolton A, Maiorana A, Guze M, Bourdeau B, Shade S, et al.
AIDS Patient Care STDS
. 2025 Feb;
39(3):102-115.
PMID: 39964750
As HIV diagnoses continue to decrease and rates of viral suppression increase in the United States, key populations of underserved individuals represent a disproportionate share of those left undiagnosed, unengaged...
3.
Krebs D, Goldhammer H, Dorfman M, Moore M, Chavis N, Psihopaidas D, et al.
AIDS Patient Care STDS
. 2025 Feb;
PMID: 39929177
Interventions that leverage telehealth technologies have the potential to improve health outcomes among people with HIV who experience multiple complex barriers to care. To assess the current state of knowledge...
4.
Moameri H, Shahrbabaki P, Tavakoli F, Saberi P, Mirzazadeh A, Goudarzi R, et al.
BMC Health Serv Res
. 2024 Nov;
24(1):1433.
PMID: 39563358
Background: Pre-exposure prophylaxis (PrEP) significantly reduces HIV transmission, but it is not commonly prescribed in Iran. Therefore, this study aimed to identify facilitators and barriers to PrEP use among four...
5.
Bakre S, Chang H, Doshi J, Goedel W, Saberi P, Chan P, et al.
JAMA Intern Med
. 2024 Aug;
184(10):1204-1211.
PMID: 39158923
Importance: Clinicians are a key component of preexposure prophylaxis (PrEP) care. Yet, no prior studies have quantitatively investigated how PrEP adherence differs by clinician specialty. Objective: To understand the association...
6.
Stoner M, Smith L, Ming K, Mancuso N, Patani H, Sukhija-Cohen A, et al.
J Acquir Immune Defic Syndr
. 2024 Feb;
96(2):136-146.
PMID: 38363868
Background: Despite improvements in antiretroviral therapy (ART) availability, suboptimal adherence is common among youth with HIV (YWH) and can increase drug resistance and poor clinical outcomes. Our study examined an...
7.
Dean L, Nunn A, Chang H, Bakre S, Goedel W, Dawit R, et al.
Health Aff (Millwood)
. 2024 Jan;
43(1):36-45.
PMID: 38190604
Oral HIV pre-exposure prophylaxis (PrEP) is highly effective for preventing HIV. Several different developments in the US either threaten to increase or promise to decrease PrEP out-of-pocket costs and access...
8.
Stoner M, Ming K, Wagner D, Smith L, Patani H, Sukhija-Cohen A, et al.
PLoS One
. 2023 Dec;
18(12):e0289919.
PMID: 38134037
Background: Young adults have a disproportionately high rate of HIV infection, high rates of attrition at all stages of the HIV care continuum, and an elevated probability of disease progression...
9.
McCuistian C, Wootton A, Legnitto-Packard D, Gruber V, Dawson-Rose C, Johnson M, et al.
BMJ Open
. 2023 Dec;
11(4):e042713.
PMID: 38058024
Objective: Youth represent a population disparately impacted by the HIV epidemic. With most new HIV diagnoses occurring among adolescents and young adults, novel approaches to address this disparity are necessary....
10.
Saberi P, Stoner M, McCuistian C, Balaban C, Ming K, Wagner D, et al.
BMJ Open
. 2023 Oct;
13(10):e077676.
PMID: 37802624
Introduction: Young adults with HIV (YWH) experience worse clinical outcomes than adults and have high rates of substance use (SU) and mental illness that impact their engagement in care and...